Here’s a quick biology lesson on semaglutide’s mechanisms of action (stick with us — we ... the manufacturer of the diabetes and weight loss drugs Mounjaro® and Zepbound®.

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

Although the exact mechanism of action has not been revealed ... and other hypoglycemic agents for diabetes treatment. Semaglutide is an ingredient in diabetes and obesity treatments developed ...

Protein is a cornerstone nutrient for maintaining overall health, but its significance becomes especially prominent for those ...

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and ...

Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert breaks down its benefits, downsides and the need for responsible rollout in a ...

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes ... from taking action against its members for making copies of semaglutide.

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...